PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the field of biopharmaceuticals, supplying promising advancements across many clinical and industrial applications. With its structural similarity to In a natural way derived human serum albumin, OsrHSA delivers a safer, much more trustworthy alternate for therapeutic use,